Intracoronary streptokinase in acute myocardial infarction. A review
Insights
Salvaging heart muscle threatened by ischemia involves reducing oxygen demand or restoring blood flow. Early restoration of blood supply, potentially with medication, appears to improve heart function and survival rates.
Area of Science:
- Cardiology
- Cardiovascular Medicine
Background:
- Myocardial infarction leads to cell death, impacting survival.
- Clinical cardiology seeks to limit myocardial loss during ischemia.
- Approaches include reducing oxygen consumption and restoring blood supply.
Purpose of the Study:
- To review strategies for salvaging myocardium threatened by ischemia.
- To evaluate interventions aimed at protecting cardiac cells from ischemia and reperfusion injury.
- To present arguments favoring early blood supply restoration combined with pharmacological therapy.
Main Methods:
- Review of pharmacological approaches to reduce myocardial oxygen consumption.
- Discussion of interventions for restoring coronary blood supply.
- Analysis of cellular protection strategies against ischemia/reperfusion.
- Evaluation of left ventricular function endpoints (wall motion, ejection fraction), mortality, and complications.
Main Results:
- Pharmacological and interventional strategies aim to preserve viable myocardium.
- Early restoration of blood supply is a key focus.
- Combined approach of early revascularization and pharmacological therapy (beta-blockade, calcium antagonists) shows promise.
- Ongoing randomized trials, including one with intracoronary streptokinase, will provide definitive proof.
Conclusions:
- Early restoration of blood supply, especially when combined with pharmacological therapy, is preferred for improving cardiac function.
- Current data suggest improved function and potential for increased life expectancy in certain patient subsets.
- Further evidence from prospective randomized studies is anticipated to confirm these findings.
Abstract:
The attempt to salvage myocardium threatened by ischemia during temporary or permanent occlusion of one or more of the nutrient arteries, is based on the observation that the major determinant of survival is the extent to which myocardium has been lost through infarction. Modern clinical cardiology has therefore looked at various approaches which might limit unnecessary loss of potentially viable myocardium. These are attempts to reduce the oxygen consumption through pharmacological means, attempts at restoring the blood supply and oxygen delivery at an early stage by manipulations on the coronary arteries and interventions aimed at "protecting" cardiac cells threatened by ischemia or reperfusion. Endpoints considered to be proof of improved left ventricular function will be wall motion and ejection fraction measurements as well as reduction in death rate and other serious cardiovascular complications. Although final proof from prospective randomized studies, one of which is carried out at this institution with intracoronary streptokinase in over 300 patients, will not be available at the time of this presentation, arguments will be provided which indicate that restoration of blood supply at an early stage, preferably supported by pharmacological therapy with beta-blockade and calcium antagonists, is to be preferred inasmuch as current data indicate improved function, and in certain subsets, improved life expectancy.
Related Concept Videos
01:14Myocarditis III: Medical Management
01:30Acute Coronary Syndrome I: Introduction
01:30Acute Coronary Syndrome III: Diagnostic Studies